International Clinical Trial: Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732933) titled 'Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models' on July 21.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Condition: Bipolar Disorder (BD) Bipolar Disorder (BPD)

Intervention: Procedure: Peripheral blood sampling for PBMC isolation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 20

Countries of Recruit...